Domestic:+91 8550986868sales@anantlabs.com
LoginSign up
/
Anant Labs

Trametinib

CAS 871700-17-3

Trametinib
In Stock

Trametinib

Cat. No. STUB-API-TRAMETINIBCAS 871700-17-3In Stock
Technical Data
Cat. No.STUB-API-TRAMETINIB
CAS871700-17-3
Mol. FormulaC26H23FIN5O4
Mol. Weight615.403 g/mol
IUPACN-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide
SMILESCC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5
InChIInChI=1S/C26H23FIN5O4/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34)
InChI KeyLIRYPHYGHXZJBZ-UHFFFAOYSA-N
Purity
Description

Overview

Trametinib, as monotherapy or in combination with dabrafenib is indicated for the treatment of melanoma and glioma. Trametinib has been used off label to treat various RASopathies, including Noonan Syndrome and Primary Intestinal Lymphangiectasia

Anant Labs manufacture and furnish high quality Trametinib impurities for global markets. Our Trametinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Synonyms

Trametinib871700-17-3GSK1120212GSK-1120212JTP 74057JTP-74057GSK 1120212TMT212trametinibumTMT-212

Looking for a specific reference standard?

Tell us what you need. Our team responds within one business day.